[link removed]
[link removed]
[link removed]
[link removed] [link removed]
Email not displaying correctly? View it in your browser ([link removed]).
[link removed]
Issue 1,726: November 29, 2023
Top Stories
* Immunize.org remembers vaccine champion Rosalynn Carter
* Immunize.org posts 12 new translations of COVID-19 and RSV VISs, and RSV Preventive Antibody Immunization Information Statement
* National Influenza Vaccination Week is December 4–8. Encourage vaccination now using CDC’s digital media toolkit.
* Influenza activity is high in southern states and rising nationwide. Vaccinate now.
* Immunize.org updates “Ask the Experts: HPV” web section
* “Using Enhanced Screening Checklists for Contraindications to Vaccination: What You Need to Know”: watch the 3-minute video, part of the Improving the Vaccination Experience Video Series on YouTube
* Vaccines in the news
Immunize.org Website and Clinical Resources
* Update: Important updates about the new Immunize.org website search features
Featured Resources
* Recap: 2024 U.S. recommended immunization schedule for children and teens released
* Recap: 2024 U.S. recommended immunization schedule for adults released
Notable Publications
* "Multilevel Implementation Strategies for Adolescent Human Papillomavirus Vaccine Uptake: A Cluster Randomized Clinical Trial" published in JAMA Pediatrics
Global News
* "House-to-House Campaign Administration of Inactivated Poliovirus Vaccine—Sokoto State, Nigeria, November 2022" published in MMWR
Upcoming Events
* Virtual: NFID hosts webinar titled “Protecting Infants from RSV: Understanding Guidance on New Prevention Tools” on December 1 at 12:00 p.m. (ET)
------------------------------------------------------------
Top Stories
------------------------------------------------------------
Immunize.org remembers vaccine champion Rosalynn Carter
Immunize.org remembers vaccine champion Rosalynn Carter and honors her legacy of tireless advocacy in support of immunization. A portion of Vaccinate Your Family's tribute ([link removed]) to the former first lady is reprinted below.
When Mrs. Carter co-founded Every Child By Two (now known as Vaccinate Your Family) in 1991, a measles epidemic was raging that had sickened 55,000 people and killed over 120 here in the United States. Within two years, Rosalynn Carter and co-founder Betty Bumpers traveled to more than a dozen states—and ultimately to all 50 states—to foster immunization efforts and build immunization coalitions. It was on these trips that the access barriers to vaccines were uncovered and systemic changes were put into place to ensure that every child was immunized on time.
Carter and Bumpers’ work to bring attention to childhood vaccines at the federal level has been credited as the catalyst behind the Vaccines for Children (VFC) program, which provides access to free vaccines to our nation’s uninsured and underinsured children. Widespread access to childhood vaccines—thanks to the VFC program—will save more than 1 million lives of children vaccinated in the U.S. since the program’s launch in 1994. . . .
Mrs. Carter and Mrs. Bumpers spent decades fighting for and implementing a bipartisan approach to vaccine policy, education, and access that focused on children and prioritized underserved families and communities. Their efforts to secure a Presidential Directive from the White House in 2000 ensures that the children and pregnant people served by WIC [Women-Infants-Children program] are offered immunization screenings and guided to services as needed. . . .
Former First Lady Rosalynn Carter lived a life of service, and we are all better for it. . . .
Above: Betty Bumpers and Rosalynn Carter honor Immunize.org founder and Executive Director Emerita Dr. Deborah Wexler in 2011 on behalf of Every Child by Two (now Vaccinate Your Family).
------------------------------------------------------------
Immunize.org posts 12 new translations of COVID-19 and RSV VISs, and RSV Preventive Antibody Immunization Information Statement
Thanks to CDC support, Immunize.org continues to expand its repository of VIS translations ([link removed]). Recently, Immunize.org posted Spanish translations for COVID-19 and RSV VISs and the RSV Preventive Antibody Immunization Information Statement (IIS). Twelve additional up-to-date translations of the three documents have now been posted. The following translations are now available:
All translations are available in print-ready PDF format.
COVID-19 VIS (view in English ([link removed]) ): RSV VIS (view in English ([link removed]) ): RSV Preventive Antibody IIS (view in English ([link removed]) ):
Armenian ([link removed])
Chinese-Simplified ([link removed])
Chinese-Traditional ([link removed])
German ([link removed])
Italian ([link removed])
Japanese ([link removed])
Korean ([link removed])
Pashto ([link removed])
Polish ([link removed])
Russian ([link removed])
Somali ([link removed])
Spanish ([link removed])
Vietnamese ([link removed]) Armenian ([link removed])
Chinese-Simplified ([link removed])
Chinese-Traditional ([link removed])
German ([link removed])
Italian ([link removed])
Japanese ([link removed])
Korean ([link removed])
Pashto ([link removed])
Polish ([link removed])
Russian ([link removed])
Somali ([link removed])
Spanish ([link removed])
Vietnamese ([link removed]) Armenian ([link removed])
Chinese-Simplified ([link removed])
Chinese-Traditional ([link removed])
German ([link removed])
Italian ([link removed])
Japanese ([link removed])
Korean ([link removed])
Pashto ([link removed])
Polish ([link removed])
Russian ([link removed])
Somali ([link removed])
Spanish ([link removed])
Vietnamese ([link removed])
The COVID-19 VIS and the RSV preventive antibody IIS are new translations. The RSV VIS was first issued July 24, 2023, and updated October 19 to reflect new pregnancy indications. Check the version date of your office copies of the RSV vaccine translations. Discard translations of the previous RSV VIS version now that a translation of the current version is available.
Navigation Tips
* To view VISs and their translations, go to the Vaccines tab, choose VISs, then choose the vaccine of interest
* To view VIS translations for a specific language, go to the Vaccines tab, choose VIS Translations, then use the Choose Language drop-down box
Related Links
* Immunize.org: Vaccine Information Statements ([link removed]) overview page for VISs in 47 languages ([link removed])
* Immunize.org: Dates of Current Vaccine Information Statements ([link removed]) (PDF)
* Immunize.org: VISs: COVID-19 vaccine ([link removed]) page
* Immunize.org: VISs: RSV vaccine ([link removed]) page
* Immunize.org: IIS: RSV preventive antibody ([link removed]) page
* CDC: What's New with VISs ([link removed]) web page
* CDC: Current VISs ([link removed]) web page
------------------------------------------------------------
National Influenza Vaccination Week is December 4–8. Encourage vaccination now using CDC’s digital media toolkit.
National Influenza Vaccination Week ([link removed]) (NIVW), observed December 4–8 this year, was established by CDC in 2005 to highlight the importance of continuing influenza vaccination activities through the holiday season and beyond. NIVW is a great time to post and share reminder messages and vaccinate all those who are not yet protected. As vaccination rates fall behind last season, many unvaccinated people risk preventable illness and hospitalization. Get the word out using CDC's 2023 NIVW Digital Media Toolkit, which includes the following assets. ([link removed])
1. Template Matte Release ([link removed]): use CDC’s article to encourage flu vaccination on your website, blog or other channels
2. Sample Newsletter Blurb ([link removed]): include CDC’s sample text copy in your email newsletter or other communications
3. Patient Reminder Messages ([link removed]): remind patients by sharing key messages through your patient portal or other reminders
4. Social Media Messages ([link removed]): use CDC’s suggested Twitter, Facebook, and Instagram graphics and copy to spread the word; schedule content to remind your networks about the importance of flu vaccination throughout the week
CDC encourages everyone to get their annual flu vaccine—especially those with chronic medical conditions and those who are pregnant. Parts of the country are already experiencing significant influenza activity, meaning there’s no time to waste for you, your patients, and your loved ones to be vaccinated against influenza.
Use #FightFlu to join the conversation all week and tag @CDCFlu on Twitter.
------------------------------------------------------------
Influenza activity is high in southern states and rising nationwide. Vaccinate now.
CDC’s Weekly U.S. Influenza Surveillance Report, FluView ([link removed]), provides a valuable snapshot of influenza activity state-by-state.
Influenza Surveillance
For week 46, ending November 18, CDC’s Weekly U.S. Influenza Surveillance Report, FluView ([link removed]) shows that seasonal influenza activity continues to increase in most parts of the country, most notably in southern, mountain, and west coast regions of the United States. Nationwide, 3.7% of patient visits reported through the Outpatient Influenza-Like Illness Surveillance Network (ILINet) were due to respiratory illness that included fever plus a cough or sore throat (i.e., influenza-like illness [ILI]). The national baseline is 2.5%. Two pediatric deaths were reported this week, bringing the total to 3 influenza-associated pediatric deaths occurring during the 2023–24 season.
RESP-NET
Visit the CDC Respiratory Virus Hospitalization Surveillance Network (RESP-NET) ([link removed]) for weekly reports of hospitalizations across the United States due to three vaccine-preventable seasonal respiratory viruses: COVID-19, influenza, and RSV.
Influenza Vaccination Dashboard
CDC's Weekly Flu Vaccination Dashboard ([link removed]) shows that as of October 28, an estimated 25 million doses of flu vaccine were administered in pharmacies and over 13 million doses in medical offices. So far, vaccine uptake appears to be lagging behind this time in 2022. It is critical to protect as many people as possible now, before influenza activity becomes widespread.
Last week, CDC posted a spotlight ([link removed]) on the new study that estimates that influenza (flu) vaccination reduced the risk of flu-related emergency department and urgent care visits and hospitalizations by almost half (40-48%) among children and adolescents during the 2022–23 season.
CDC recommends everyone age 6 months and older get annual influenza vaccination. Influenza and other vaccines (e.g., COVID-19 vaccine, RSV vaccine) may be given at the same visit, if needed. Locate influenza and COVID-19 vaccines in your area by entering your zip code in the VaccineFinder on Vaccines.gov ([link removed]) or Vacunas.gov ([link removed]). To be listed as a provider by VaccineFinder, see the information on this website ([link removed]).
Related Links
* CDC: Weekly National Flu Vaccination Dashboard ([link removed]) main page
* CDC: FluView ([link removed]) main page
* CDC: RESP-NET ([link removed]) main page
* Immunize.org: free educational materials and patient handouts related to influenza ([link removed])
* Immunize.org: Vaccines: Influenza ([link removed]) main page
* Immunize.org: Ask the Experts: Influenza ([link removed]) main page
------------------------------------------------------------
Immunize.org updates “Ask the Experts: HPV” web section
Immunize.org reviewed and updated its popular Ask the Experts: HPV ([link removed]) web page, updating disease epidemiology.
[link removed]
Immunize.org’s Ask the Experts ([link removed]) main page leads you to 30 web pages on various topics with more than 1,200 common or challenging questions and answers about vaccines and their administration. Immunize.org’s team of experts includes Kelly L. Moore, MD, MPH (team lead), Carolyn B. Bridges, MD, FACP, and Iyabode Beysolow, MD, MPH.
Related Links
* Immunize.org: Ask the Experts ([link removed]) main page with more than 1,200 questions and answers
* Immunize.org: Ask the Experts: HPV ([link removed] ) web page
------------------------------------------------------------
“Using Enhanced Screening Checklists for Contraindications to Vaccination: What You Need to Know”: watch the 3-minute video, part of the Improving the Vaccination Experience Video Series on YouTube
This week’s featured video is Using Enhanced Screening Checklists for Contraindications to Vaccination: What You Need to Know ([link removed]) . Four of Immunize.org’s screening checklists for contraindications to vaccination have been enhanced to screen for a history of vaccination-related dizziness or fainting, and for vaccination-related anxiety. When screening is positive, you can support vaccine recipients with simple techniques to improve the vaccination experience and reduce the risk of fainting. This 3-minute video is part of Immunize.org’s new Improving the Vaccination Experience Video Series. It is available on our YouTube channel ([link removed]) , along with our full collection of quick video answers to popular Ask the Experts ([link removed]) questions.
This week's featured video highlights these clinical resources:
* Screening Checklist for Contraindications to HPV, MenACWY, MenB, and Tdap Vaccines for Teens ([link removed])
* Screening Checklist for Contraindications to Injectable Influenza Vaccination ([link removed])
* Screening Checklist for Contraindications to Vaccines for Adults ([link removed])
* Screening Checklist for Contraindications to Vaccines for Children and Teens ([link removed])
Immunize.org’s series of short videos introduces you to different ways to improve the vaccination experience for infants, children, teens, and adults. Three are for a general audience, and three are for healthcare professionals. As with all Immunize.org resources, these videos are free to download, link, copy, and share.
Like, follow, and share Immunize.org’s social media accounts and encourage colleagues and others interested in vaccination to do likewise:
* Facebook at ImmunizeOrg ([link removed])
* Instagram at ImmunizeOrg ([link removed])
* LinkedIn at ImmunizeOrg ([link removed])
* YouTube at ImmunizeOrg ([link removed])
* X (Twitter) at ImmunizeOrg ([link removed])
Navigation Tips
* To find all of Immunize.org’s screening checklists, go to the Clinical Resources tab, click on Clinical Resources A–Z, and choose Screening Checklists from the menu options on the right.
* To find all of Immunize.org’s clinical resources to manage vaccination-related anxiety, go to the Clinical Resources tab, click on Clinical Resources A–Z, and choose Addressing Vaccination Anxiety from the menu options on the right.
Related Links
* Immunize.org: YouTube channel ([link removed])
* Immunize.org: Clinical Resources: Addressing Vaccination Anxiety ([link removed]) main page
* Immunize.org: Improving the Vaccination Experience: Reducing Pain and Anxiety for Children and Adults ([link removed]) on-demand webinar (2/28/23)
* Immunize.org: Improving the Vaccination Experience: Accessible Vaccination for Neurodiverse People at Any Age ([link removed]) on-demand webinar (12/13/22)
* Immunize.org: Clinical Resources: Screening Checklists ([link removed]) main page (includes questions to screen for a history of fainting or for vaccination-related anxiety)
------------------------------------------------------------
Vaccines in the news
These recent articles convey the potential risks of vaccine-preventable diseases and the importance of vaccination.
* Barron’s: Golden Age of Vaccines Is Here. What It Means for You. ([link removed]) (11/21/23)
* Nature: Polio Is on the Brink of Eradication. Here’s How to Keep It from Coming Back. ([link removed]) (11/21/23)
* STAT: Respiratory Viruses, Thrown Out of Whack by COVID, Appear to Be Falling Back into Seasonal Order ([link removed]) (11/20/23)
* WebMD: This Season’s Flu Shot Is Shaping Up to Be Very Effective ([link removed]) (11/20/23)
* The Hill: One-Third in New Survey Worried about Catching Flu, COVID, RSV in Next Three Months ([link removed]) (11/20/23)
* Washington Post: Seniors Made Up 63 Percent of COVID Hospitalizations Earlier This Year ([link removed]) (11/20/23)
* NBC: “Sustained Increases” Reported in Flu Nationwide, as RSV Hits Kids Hard ([link removed]) (11/17/23)
------------------------------------------------------------
Immunize.org Website and Clinical Resources
------------------------------------------------------------
Update: Important updates about the new Immunize.org website search features
We hope you are learning your way around our redesigned website! As noted in last week’s IZ Express, some elements of the site’s search functions are not yet working properly. We are pleased to report that the slow response times to keyword searches and filters is now near normal (about 3 seconds instead of 7 seconds).
We continue to recommend that you start keyword searches only on the “All Questions” page of Ask the Experts ([link removed]) or the “Search All Clinical Resources” page of Clinical Resources ([link removed]) . In addition, the selection of a filter subcategory will also return everything in the category (not just the subcategory).
We will continue to keep our IZ Express readers up to date as these remaining technical issues are resolved. Thank you for your support.
Related Links
* Immunize.org: Ask the Experts: View All Questions ([link removed])
* Immunize.org: Clinical Resources: Search All Clinical Resources ([link removed])
------------------------------------------------------------
Featured Resources
------------------------------------------------------------
Recap: 2024 U.S. recommended immunization schedule for children and teens released
In a break with its tradition of publishing the new annual schedule each February, on November 16, CDC posted the 2024 recommended immunization schedule for children and adolescents ([link removed]) on CDC's Immunization Schedules for Healthcare Providers ([link removed]) web page. The schedule includes an addendum page (currently empty) that will be filled later as ACIP issues updates to its recommendations throughout 2024. The MMWR publication of the schedule will occur in January. The purpose of publishing the schedule earlier is to allow more time for immunization providers to train and prepare their teams.
The updated schedule for children and adolescents includes:
* Table 1: Recommendations for Ages 18 Years or Younger, United States, 2024 ([link removed])
* Table 2: Catch-Up Immunization Schedule for Children and Adolescents Who Start Late or Who Are More than 1 Month Behind ([link removed])
* Table 3: Child and Adolescent Immunization Schedule by Medical Indication ([link removed])
Access the full-color, 15-page PDF of the child/adolescent schedule ([link removed]).
View what changed on the child/adolescent schedule for 2024 ([link removed]).
As in previous years, Immunize.org will produce sturdy, waterproof, laminated copies of these schedules for sale in early 2024. Preordering information will be shared in a special Shop Edition of IZ Express as soon as it is available.
Related Links
* CDC: Schedule-Related Resources for Healthcare Providers ([link removed]) web page
* CDC: For You and Your Family: Parent-Friendly Schedules and More Vaccination Resources ([link removed]) web page (pending update)
* CDC: Resources for Healthcare Providers ([link removed]) web page
------------------------------------------------------------
Recap: 2024 U.S. recommended immunization schedule for adults released
CDC moved up the online release of the 2024 recommended immunization schedule for adults ([link removed]) three months earlier than in the past in order to give immunization providers earlier access to new and updated current recommendations on the immunization schedule. On November 16, CDC posted the 2024 recommended immunization schedule for adults on CDC’s Immunization Schedules for Healthcare Providers ([link removed]) web page. The online schedule includes an addendum page (currently empty) that will be filled later as ACIP issues updates to its recommendations throughout 2024. The typical MMWR publication of the schedule will be issued in January 2024.
The updated schedule for adults includes:
* Table 1: Recommendations for Ages 19 Years or Older, United States, 2024 ([link removed])
* Table 2: Adult Immunization Schedule by Medical Condition and Other Indication ([link removed])
Access the full-color, 13-page PDF of the adult schedule ([link removed]).
View what changed on the adult schedule for 2024 ([link removed]).
As in previous years, Immunize.org will produce sturdy, waterproof, laminated copies of these schedules for sale in early 2024. Preordering information will be shared in a special Shop Edition of IZ Express as soon as it is available.
Related Links
* CDC: Schedule-Related Resources for Healthcare Providers ([link removed]) web page
* CDC: There Are Vaccines You Need as an Adult ([link removed]) web page includes links for Adult Vaccinations ([link removed]) and Pregnancy and Vaccination ([link removed])
* CDC: Resources for Healthcare Providers ([link removed]) web page
------------------------------------------------------------
Notable Publications
------------------------------------------------------------
"Multilevel Implementation Strategies for Adolescent Human Papillomavirus Vaccine Uptake: A Cluster Randomized Clinical Trial" published in JAMA Pediatrics
In the November 20 issue, JAMA Pediatrics published Multilevel Implementation Strategies for Adolescent Human Papillomavirus Vaccine Uptake: A Cluster Randomized Clinical Trial ([link removed]). The study evaluated the individual and combined impact of two evidence-based interventions on HPV vaccination rates among 11- and 12-year-old children. Parents of eligible patients were mailed reminder or recall messages following their children’s birthdays. Healthcare professionals received confidential feedback on their personal in-office success with HPV vaccine uptake via intracampus mail. A portion of the results section appears below.
Parent reminder/recall resulted in 34.6% receiving a dose of HPV vaccine, health care professional audit/feedback, 30.4%, both interventions together resulted in 39.7%—all contrasted to usual care, 21.9%. Compared with usual care, the odds of HPV vaccination were higher for parent reminder/recall (odds ratio [OR], 1.56 . . .) and for the combination of parent reminder/recall and health care professional audit/feedback (OR, 2.03 . . . ). Health care professional audit/feedback alone did not differ significantly from usual care. . . .
------------------------------------------------------------
Global News
------------------------------------------------------------
"House-to-House Campaign Administration of Inactivated Poliovirus Vaccine—Sokoto State, Nigeria, November 2022" published in MMWR
CDC published Risk House-to-House Campaign Administration of Inactivated Poliovirus Vaccine—Sokoto State, Nigeria, November 2022 ([link removed]) on November 24 in MMWR ([link removed]). The preliminary conclusions and actions section appears below.
This pilot study demonstrated that administering an injectable vaccine in a house-to-house campaign with needle-free jet injector devices is feasible and can achieve high coverage. Intensification of RI, including increasing immunization sessions, provision of supportive supervision, and ensuring vaccine availability, will be needed to complete vaccination of children in the pilot ward with the second fIPV dose. Additional pilot studies targeting larger populations should be conducted before this approach can be applied in other low-IPV coverage areas.
The map of IPV coverage in Nigeria is shown above. Access the MMWR article in HTML ([link removed]) or PDF ([link removed]).
Related Link
* MMWR's main page ([link removed]) provides access to the MMWR family of publications
------------------------------------------------------------
Upcoming Events
------------------------------------------------------------
Virtual: NFID hosts webinar titled “Protecting Infants from RSV: Understanding Guidance on New Prevention Tools” on December 1 at 12:00 p.m. (ET)
NFID will host a webinar titled Protecting Infants from RSV: Understanding Guidance on New Prevention Tools ([link removed]), 12:00–1:05 p.m. (ET) on December 1. This panel, featuring experts from NFID, National Coalition for Infant Health, and Association of Women’s Health, Obstetric, and Neonatal Nurses, will include a discussion on new tools to protect infants and young children from RSV.
There is no fee to participate in this activity, but preregistration is required.
Register for the webinar ([link removed]).
NFID hosts monthly webinars ([link removed]) to increase awareness of the importance of infectious disease prevention and treatment. Topics include vaccines recommended by the Advisory Committee on Immunization Practices (ACIP), antibiotic resistance and stewardship, best practices and communication skills, and complementary tools and resources. CE is available for select recordings. View all archived NFID webinars ([link removed]).
------------------------------------------------------------
For more upcoming events, visit our Calendar of Events ([link removed]).
Editorial Information
Editor-in-Chief
Kelly L. Moore, MD, MPH
Managing Editor
John D. Grabenstein, RPh, PhD
Associate Editor
Sharon G. Humiston, MD, MPH
Writer/Publication Coordinator
Taryn Chapman, MS
Courtnay Londo, MA
Style and Copy Editor
Marian Deegan, JD
Web Edition Managers
Arkady Shakhnovich
Jermaine Royes
Contributing Writer
Laurel H. Wood, MPA
Technical Reviewer
Kayla Ohlde
About IZ Express
Immunize.org welcomes redistribution of this issue of IZ Express or selected articles.
When you do so, please add a note that Immunize.org is the source of the material and provide a link to this issue ([link removed]).
IZ Express is supported in part by Grant No. 1NH23IP922654 from the National Center for Immunization and Respiratory Diseases, CDC. Its contents are solely the responsibility of Immunize.org and do not necessarily represent the official views of CDC.
IZ Express Disclaimer ([link removed])
ISSN: 2771-8085
To unsubscribe to this publication, go to: [link removed]
==============================================
Unsubscribe
[email protected] from this list:
[link removed]